# SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

> **NCT00003720** · PHASE1 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** semaxanib

## Key facts

- **NCT ID:** NCT00003720
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003720, "SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00003720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*